Reinforces MINDCURE’s financial integrity and provides greater visibility to U.S. Investors VANCOUVER, BC, Sept. 30, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research for psychedelics, announced today that it has graduated from OTCQB Venture Market to now trade on the OTCQX Best Market (“…


Previous articlePharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors
Next articleMindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce Linton